Owlstone Medical's Series B - II Round

Owlstone Medical raised a round of funding on March 27, 2017. Investors include Aviva Ventures.

Owlstone Medical is a diagnostics company developing a breathalyzer for disease detection. Its Breath Biopsy platform enables early detection across multiple cancers and a range of other conditions. B…

Articles about Owlstone Medical's Series B - II Round: